-+ 0.00%
-+ 0.00%
-+ 0.00%

Allogene Therapeutics Q3 EPS $(0.15), Inline

Benzinga·11/05/2026 21:08:21
Diffusion vocale
Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 21.05 percent increase over losses of $(0.19) per share from the same period last year.